NO20100667L - Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater - Google Patents

Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater

Info

Publication number
NO20100667L
NO20100667L NO20100667A NO20100667A NO20100667L NO 20100667 L NO20100667 L NO 20100667L NO 20100667 A NO20100667 A NO 20100667A NO 20100667 A NO20100667 A NO 20100667A NO 20100667 L NO20100667 L NO 20100667L
Authority
NO
Norway
Prior art keywords
intermediates
preparation
benzoxazine derivatives
benzoxazine
derivatives
Prior art date
Application number
NO20100667A
Other languages
English (en)
Other versions
NO330090B1 (no
Inventor
Kouji Sato
Yoshihiro Takayanagi
Katsuhiko Okano
Keiji Nakayama
Akihiro Imura
Mikihiro Itoh
Tsutomu Yagi
Yukinari Kobayashi
Tomoyuki Nagai
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20100667L publication Critical patent/NO20100667L/no
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of NO330090B1 publication Critical patent/NO330090B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/34—Preparation of optical isomers by separation of optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/36—Racemisation of optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20100667A 1999-09-08 2010-05-07 Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater NO330090B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP25395899 1999-09-08
JP27801999 1999-09-30
JP2000239262 2000-08-08
JP2000239256 2000-08-08
PCT/JP2000/006094 WO2001018005A1 (en) 1999-09-08 2000-09-07 Process for the preparation of benzoxazine derivatives and intermediates therefor

Publications (2)

Publication Number Publication Date
NO20100667L true NO20100667L (no) 2002-05-08
NO330090B1 NO330090B1 (no) 2011-02-14

Family

ID=27478308

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20021124A NO329330B1 (no) 1999-09-08 2002-03-06 Fremgangsmate for fremstilling av benzoksazinderviater
NO20100667A NO330090B1 (no) 1999-09-08 2010-05-07 Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20021124A NO329330B1 (no) 1999-09-08 2002-03-06 Fremgangsmate for fremstilling av benzoksazinderviater

Country Status (12)

Country Link
US (3) US6872823B1 (no)
EP (4) EP1211254B1 (no)
JP (5) JP4302350B2 (no)
KR (3) KR100914396B1 (no)
CN (2) CN1195759C (no)
AU (1) AU6873700A (no)
CA (3) CA2660917C (no)
ES (4) ES2472240T3 (no)
HK (1) HK1043131B (no)
NO (2) NO329330B1 (no)
TW (1) TWI254048B (no)
WO (1) WO2001018005A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100914396B1 (ko) * 1999-09-08 2009-08-31 다이이찌 산쿄 가부시키가이샤 벤즈옥사진 유도체의 제조방법 및 이의 중간체
US7425628B2 (en) * 2001-10-03 2008-09-16 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
US7629458B2 (en) 2001-10-03 2009-12-08 Teva Pharmaceutical Industries Ltd. Preparation of levofloxacin and hemihydrate thereof
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
CN100580009C (zh) * 2005-12-31 2010-01-13 四川东材科技集团股份有限公司 一种含硼苯并恶嗪树脂的制备方法
US7902227B2 (en) 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
CN101659669B (zh) * 2009-09-04 2011-07-20 诚达药业股份有限公司 左旋氧氟沙星的制备方法
CN101768167B (zh) * 2010-01-15 2012-07-04 浙江东亚药业有限公司 左氧氟沙星的缩哌合成方法
CN101836993B (zh) 2010-05-20 2011-06-22 山东大学 2，3-二氢-3-羟甲基-6-氨基-[1，4]-苯并噁嗪在制备诱导胚胎干细胞向血管内皮细胞分化药物中的应用
US10209243B2 (en) 2010-08-05 2019-02-19 Koninklijke Philips N.V. Cardiomyocyte containing device, manufacturing method and measuring method
CN103360409B (zh) * 2012-04-06 2016-02-10 天方药业有限公司 氧氟羧酸制备方法
KR20160003641A (ko) * 2013-04-30 2016-01-11 쓰리엠 이노베이티브 프로퍼티즈 컴파니 폴리(벤족사진)의 제조 방법
WO2016209063A2 (ko) * 2015-06-25 2016-12-29 고려대학교 산학협력단 평균 밀도 조절이 가능한 구조체 및 이를 이용한 물질 전환 및 선택적 결합 공정
US20180324299A1 (en) * 2017-05-08 2018-11-08 T-Mobile Usa, Inc. Network-controlled robocall and scam call handling
CN112877217B (zh) * 2020-12-10 2022-04-15 贵州大学 一种黄褐奈尼兹皮真菌菌株及其降解鸡毛中的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56417B2 (no) * 1973-07-05 1981-01-08
JPS5829789A (ja) * 1981-08-17 1983-02-22 Dai Ichi Seiyaku Co Ltd ピリドベンズオキサジン誘導体
JPS5872588A (ja) * 1981-10-27 1983-04-30 Dai Ichi Seiyaku Co Ltd ピリド〔１，２，３−ｄｅ〕−１，４−ベンゾオキサジン誘導体の製造法
NO166131C (no) * 1985-06-20 1991-06-05 Daiichi Seiyaku Co Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
JPH0720946B2 (ja) 1985-10-11 1995-03-08 第一製薬株式会社 光学活性３−メチルベンゾオキサジン誘導体およびその製法
ZA864518B (en) * 1985-06-20 1987-03-25 Daiichi Seiyaku Co Optically active pyridobenzoxazine derivatives and intermediates thereof
JP2573269B2 (ja) 1986-12-25 1997-01-22 第一製薬株式会社 光学活性ベンゾオキサジン
NO172846C (no) * 1987-12-25 1993-09-15 Daiichi Seiyaku Co Fremgangsmaate for fremstilling av 7,8-dihalogen-3-metyl-2,3-dihydro-2m-benzoksazinderivater og propoksybenzenderivater for utoevelse av fremgangsmaaten.
JP2612327B2 (ja) 1987-12-25 1997-05-21 第一製薬株式会社 プロポキシベンゼン誘導体およびその製法
JP2769174B2 (ja) 1987-12-28 1998-06-25 第一製薬株式会社 縮合オキサジンの製法
ES2014560A6 (es) * 1988-12-30 1990-07-16 Marga Investigacion Proceso para la preparacion de un nuevo reactivo organo-sililpolifosforico y su aplicacion al proceso de sontesis de 3-carboxi-quinolonas o azaquinolonas y sus sales.
JP2771871B2 (ja) 1989-12-13 1998-07-02 第一製薬株式会社 光学活性プロポキシベンゼン誘導体の製法
KR920004385A (ko) * 1990-08-09 1992-03-27 와꾸나가 기스께 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제
DK0508307T3 (da) * 1991-04-08 1995-12-27 Sumitomo Chemical Co Optisk aktive sekundære aminforbindelser, fremgangsmåde til fremstilling af en optisk aktiv sekundær aminforbindelse og fremgangsmåde til fremstilling af en optisk aktiv carboxylsyre ved anvendelse af denne forbindelse
JPH07501835A (ja) * 1992-10-07 1995-02-23 デリバドス・デル・エチロ・ソシエダッド・アノニマ オフロキサジン，レボフロキサジン及び誘導体の合成に使用されるベンゾキサジンの製造法
CN1066136C (zh) * 1994-07-21 2001-05-23 中国医药研究开发中心 吡啶并苯并噁嗪衍生物的中间体及其制备方法
US5644056A (en) 1995-06-07 1997-07-01 Hoechst Celanese Corporation Method of preparing 7,8-difluoro-2,3-dihydro-3-methyl-4H-1, 4-benzoxazine
WO1998022441A2 (en) * 1996-11-22 1998-05-28 Elan Pharmaceuticals, Inc. N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
KR100914396B1 (ko) * 1999-09-08 2009-08-31 다이이찌 산쿄 가부시키가이샤 벤즈옥사진 유도체의 제조방법 및 이의 중간체

Also Published As

Publication number Publication date
CA2380359A1 (en) 2001-03-15
KR100954299B1 (ko) 2010-04-23
EP2218722B9 (en) 2013-06-19
KR20090123026A (ko) 2009-12-01
EP2284174A1 (en) 2011-02-16
CN1379779A (zh) 2002-11-13
US7189847B2 (en) 2007-03-13
EP2218722A3 (en) 2011-05-11
EP2284174B1 (en) 2014-03-05
KR20020035867A (ko) 2002-05-15
WO2001018005A1 (en) 2001-03-15
NO20021124L (no) 2002-05-08
CA2380359C (en) 2011-11-29
KR20090077024A (ko) 2009-07-13
EP2360160A1 (en) 2011-08-24
US6872823B1 (en) 2005-03-29
ES2458545T3 (es) 2014-05-06
JP2009167202A (ja) 2009-07-30
JP4302350B2 (ja) 2009-07-22
EP1211254A1 (en) 2002-06-05
HK1043131B (en) 2014-08-29
EP1211254B1 (en) 2014-05-07
CN1532181A (zh) 2004-09-29
HK1043131A1 (en) 2002-09-06
TWI254048B (en) 2006-05-01
NO329330B1 (no) 2010-09-27
JP2009235077A (ja) 2009-10-15
CN100537519C (zh) 2009-09-09
US20060014947A1 (en) 2006-01-19
JP5149238B2 (ja) 2013-02-20
EP2218722B1 (en) 2013-03-13
EP1211254A4 (en) 2006-05-03
WO2001018005A8 (en) 2001-05-25
KR100947758B1 (ko) 2010-03-18
NO20021124D0 (no) 2002-03-06
CA2685440A1 (en) 2001-03-15
JP2009173665A (ja) 2009-08-06
ES2424813T3 (es) 2013-10-08
JP5106478B2 (ja) 2012-12-26
US7087778B2 (en) 2006-08-08
AU6873700A (en) 2001-04-10
CA2660917A1 (en) 2001-03-15
NO330090B1 (no) 2011-02-14
KR100914396B1 (ko) 2009-08-31
CA2660917C (en) 2012-01-03
ES2409383T3 (es) 2013-06-26
JP4358295B2 (ja) 2009-11-04
EP2218722A2 (en) 2010-08-18
JP2009221209A (ja) 2009-10-01
CA2685440C (en) 2011-11-15
US20050027119A1 (en) 2005-02-03
EP2360160B1 (en) 2013-07-24
ES2472240T3 (es) 2014-06-30
JP4358296B2 (ja) 2009-11-04
CN1195759C (zh) 2005-04-06

Similar Documents

Publication Publication Date Title
NO20015017D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20010318D0 (no) Fremgangsmåte for fremstilling av Citalopram
NO20010319L (no) Fremgangsmate for fremstilling av Citalopram
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20006039L (no) Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin
NO20024256L (no) Fremgangsmåte for fremstilling av pyrimidonderivater med antifungal aktivitet
NO20021124L (no) Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor
NO20032048D0 (no) Fremgangsmåte for fremstilling av latent antitrombin III
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20021368D0 (no) Fremgangsmåte for fremstilling av fenyleddiksyre-derivater
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20020059L (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20013407L (no) Fremgangsmate for fremstilling av kinolinkarbaldehyd
NO20013995D0 (no) Fremgangsmate for fremstilling av L-sorbose
NO20020308D0 (no) Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten
NO20022956D0 (no) Fremgangsmåte for fremstilling av nitroguanidin
NO20032297L (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20005818D0 (no) Forbedret fremgangsmåte for fremstilling av farmasöytisk verdifulle norbenzomorfan-derivater
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20020670L (no) Fremgangsmåte for fremstilling av kinolin-5,8-dioner
NO20014451D0 (no) Fremgangsmåte for fremstilling av tiazolidinderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees